Meanwhile, only one case of SMARCA4-deficient SCLC receiving an ICI has been reported, highlighting the need for further research on the efficacy of immunotherapy in all types of lung cancer with the loss of SMARCA4. Here, SMARCA4 is linked to lung cancer.